146 related articles for article (PubMed ID: 38448761)
1. Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study.
Rinaldi M; Gatti M; Tonetti T; Nocera D; Ambretti S; Berlingeri A; Nigrisoli G; Pierucci E; Siniscalchi A; Pea F; Viale P; Giannella M
Ann Intensive Care; 2024 Mar; 14(1):36. PubMed ID: 38448761
[TBL] [Abstract][Full Text] [Related]
2. Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP.
Gatti M; Rinaldi M; Tonetti T; Siniscalchi A; Viale P; Pea F
Antibiotics (Basel); 2024 Mar; 13(4):. PubMed ID: 38666972
[TBL] [Abstract][Full Text] [Related]
3. Surgical intensive care - current and future challenges?
Rohrig SAH; Lance MD; Faisal Malmstrom M
Qatar Med J; 2019; 2019(2):3. PubMed ID: 31976309
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Outcomes of Multi-Drug Resistant Blood Stream Infections Among Nursing Home Residents Admitted to an Acute Care Hospital.
Aliyu S; McGowan K; Hussain D; Kanawati L; Ruiz M; Yohannes S
J Intensive Care Med; 2022 Apr; 37(4):565-571. PubMed ID: 33938320
[TBL] [Abstract][Full Text] [Related]
5. Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing
Gatti M; Rinaldi M; Tonetti T; Siniscalchi A; Viale P; Pea F
Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136770
[TBL] [Abstract][Full Text] [Related]
6. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients.
Bartoletti M; Giannella M; Lewis R; Caraceni P; Tedeschi S; Paul M; Schramm C; Bruns T; Merli M; Cobos-Trigueros N; Seminari E; Retamar P; Muñoz P; Tumbarello M; Burra P; Torrani Cerenzia M; Barsic B; Calbo E; Maraolo AE; Petrosillo N; Galan-Ladero MA; D'Offizi G; Bar Sinai N; Rodríguez-Baño J; Verucchi G; Bernardi M; Viale P;
Clin Microbiol Infect; 2018 May; 24(5):546.e1-546.e8. PubMed ID: 28818628
[TBL] [Abstract][Full Text] [Related]
7. Microbiological and Clinical Characteristics of Bloodstream Infections in General Intensive Care Unit: A Retrospective Study.
Wu HN; Yuan EY; Li WB; Peng M; Zhang QY; Xie KL
Front Med (Lausanne); 2022; 9():876207. PubMed ID: 35573022
[TBL] [Abstract][Full Text] [Related]
8. Early- and Late-Onset Bloodstream Infections in the Intensive Care Unit: A Retrospective 5-Year Study of Patients at a University Hospital in China.
Xie J; Li S; Xue M; Yang C; Huang Y; Chihade DB; Liu L; Yang Y; Qiu H
J Infect Dis; 2020 Mar; 221(Suppl 2):S184-S192. PubMed ID: 32176791
[TBL] [Abstract][Full Text] [Related]
9. Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.
Viale P; Sandrock CE; Ramirez P; Rossolini GM; Lodise TP
Ann Intensive Care; 2023 Jun; 13(1):52. PubMed ID: 37322293
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study.
Palanisamy N; Vihari N; Meena DS; Kumar D; Midha N; Tak V; Sharma A; Bohra GK; Kothari N; Dutt N; Bhatia PK; Garg MK; Misra S
BMC Infect Dis; 2021 Sep; 21(1):933. PubMed ID: 34496787
[TBL] [Abstract][Full Text] [Related]
11. Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" Study.
Bavaro DF; Diella L; Belati A; De Gennaro N; Fiordelisi D; Papagni R; Guido G; De Vita E; Frallonardo L; Camporeale M; Pellegrino C; Denicolò S; Ranieri E; Mariani MF; Brindicci G; Ronga L; Di Gennaro F; Mosca A; Saracino A
Open Forum Infect Dis; 2022 Oct; 9(10):ofac488. PubMed ID: 36267259
[TBL] [Abstract][Full Text] [Related]
12. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
Magira EE; Islam S; Niederman MS
Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared.
Cogliati Dezza F; Arcari G; Alessi F; Valeri S; Curtolo A; Sacco F; Ceccarelli G; Raponi G; Alessandri F; Mastroianni CM; Venditti M; Oliva A
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884179
[TBL] [Abstract][Full Text] [Related]
14. Patterns of microbial resistance in bloodstream infections of hemodialysis patients: a cross-sectional study from Palestine.
AbuTaha SA; Al-Kharraz T; Belkebir S; Abu Taha A; Zyoud SH
Sci Rep; 2022 Oct; 12(1):18003. PubMed ID: 36289278
[TBL] [Abstract][Full Text] [Related]
15. Bloodstream infections in older population: epidemiology, outcome, and impact of multidrug resistance.
de Laroche M; Fellous L; Salomon E; Saadeh D; Duran C; Bouchand F; Lequintrec JL; Teillet L; Gaillard JL; Seridi Z; Michelon H; Dinh A
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1665-1672. PubMed ID: 33694038
[TBL] [Abstract][Full Text] [Related]
16. The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria.
Yamada K; Imoto W; Yamairi K; Shibata W; Namikawa H; Yoshii N; Fujimoto H; Nakaie K; Okada Y; Fujita A; Kawaguchi H; Shinoda Y; Nakamura Y; Kaneko Y; Yoshida H; Kakeya H
J Infect Chemother; 2019 Dec; 25(12):1001-1006. PubMed ID: 31255524
[TBL] [Abstract][Full Text] [Related]
17. Chlorhexidine washing in intensive care does not reduce bloodstream infections, blood culture contamination and drug-resistant microorganism acquisition: an interrupted time series analysis.
Kengen R; Thoonen E; Daveson K; Loong B; Rodgers H; Beckingham W; Kennedy K; Suwandarathne R; van Haren F
Crit Care Resusc; 2018 Sep; 20(3):231-240. PubMed ID: 30153786
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
Qu J; Feng C; Li H; Lv X
Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
